{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:55:19Z","timestamp":1790056519579,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,24]],"date-time":"2015-05-24T00:00:00Z","timestamp":1432425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1430-7","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T09:04:26Z","timestamp":1432371866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Charlotte E L","family":"Klaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijsbert D","family":"Musters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A","family":"Bemelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J A","family":"Punt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J","family":"Verwaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel GW","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend GJ","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila DW","family":"van der Bilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Boerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre JA","family":"Bremers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus WA","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina MU","family":"van Grevenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick HJ","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace HJT","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen A","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmus JHJ","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Pon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A","family":"Radema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van Ramshorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurriaan B","family":"Tuynman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A","family":"te Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus J","family":"Wiezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes HW","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J","family":"Tanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,24]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2014","unstructured":"Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"1430_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/BF02050360","volume":"34","author":"JT Brodsky","year":"1991","unstructured":"Brodsky JT, Cohen a M. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum. 1991;34:723\u20137.","journal-title":"Dis Colon Rectum"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","volume":"30","author":"MAG Elferink","year":"2015","unstructured":"Elferink MAG, de Jong KP, Klaase JM, Siemerink EJ, de Wilt JHW. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis. 2015;30:205\u201312.","journal-title":"Int J Colorectal Dis"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/DCR.0b013e3181a745a4","volume":"52","author":"S Noura","year":"2009","unstructured":"Noura S, Ohue M, Seki Y, Yano M, Ishikawa O, Kameyama M. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection. DisColon Rectum. 2009;52:1312\u201320.","journal-title":"DisColon Rectum"},{"key":"1430_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1245\/s10434-007-9591-5","volume":"15","author":"S Rekhraj","year":"2008","unstructured":"Rekhraj S, Aziz O, Prabhudesai S, Zacharakis E, Mohr F, Athanasiou T, et al. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis. Ann Surg Oncol. 2008;15:60\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jso.20109","volume":"87","author":"SH Yang","year":"2004","unstructured":"Yang SH, Lin JK, Lai CR, Chen CC, Li AF, Liang WY, et al. Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol. 2004;87:167\u201373.","journal-title":"J Surg Oncol"},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717\u201325.","journal-title":"Int J Cancer"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van RS, de BE, van Sloothen GW, van TH, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/1471-2407-10-689","volume":"10","author":"JO Pelz","year":"2010","unstructured":"Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, et al. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10:689.","journal-title":"BMC Cancer"},{"key":"1430_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol"},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","volume":"18","author":"YL Klaver","year":"2012","unstructured":"Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J Gastroenterol. 2012;18:5489\u201394.","journal-title":"World J Gastroenterol"},{"key":"1430_CR12","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/annonc\/mdq762","volume":"22","author":"YL Klaver","year":"2011","unstructured":"Klaver YL, Lemmens VE, Creemers GJ, Rutten HJ, Nienhuijs SW, de Hingh IH. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol. 2011;22:2250\u20136.","journal-title":"Ann Oncol"},{"key":"1430_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archsurg.138.1.26","volume":"138","author":"P Shen","year":"2003","unstructured":"Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg. 2003;138:26\u201333.","journal-title":"Arch Surg"},{"key":"1430_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/BF02409050","volume":"3","author":"S Schneebaum","year":"1996","unstructured":"Schneebaum S, Arnold MW, Staubus A, Young DC, Dumond D, Martin EW. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol. 1996;3:44\u201350.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/1096-9098(200005)74:1<41::AID-JSO10>3.0.CO;2-R","volume":"74","author":"F Cavaliere","year":"2000","unstructured":"Cavaliere F, Perri P, Di Filippo F, Giannarelli D, Botti C, Cosimelli M, et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol. 2000;74:41\u20134.","journal-title":"J Surg Oncol"},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J","volume":"88","author":"AC Beaujard","year":"2000","unstructured":"Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer. 2000;88:2512\u20139.","journal-title":"Cancer"},{"key":"1430_CR18","unstructured":"Fujimura T, Yonemura Y, Fujita H, Michiwa Y, Kawamura T, Nojima N, et al. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int Surg. 1999;84:60\u20136."},{"key":"1430_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1046\/j.1365-2168.2001.01701.x","volume":"88","author":"AJ Witkamp","year":"2001","unstructured":"Witkamp AJ, de BE, Kaag MM, van Slooten GW, van CF, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg. 2001;88:458\u201363.","journal-title":"Br J Surg"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","volume":"92","author":"D Elias","year":"2001","unstructured":"Elias D, Blot F, El OA, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92:71\u20136.","journal-title":"Cancer"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1245\/ASO.2004.09.008","volume":"11","author":"D Elias","year":"2004","unstructured":"Elias D, Delperro J-R, Sideris L, Benhamou E, Pocard M, Baton O, et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol. 2004;11:518\u201321.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000313480006600607","volume":"66","author":"BW Loggie","year":"2000","unstructured":"Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg. 2000;66:561\u20138.","journal-title":"Am Surg"},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1053\/ejso.2000.1095","volume":"27","author":"P Piso","year":"2001","unstructured":"Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol. 2001;27:286\u201390.","journal-title":"Eur J Surg Oncol"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0003-3944(00)00253-4","volume":"125","author":"Y Rey","year":"2000","unstructured":"Rey Y, Porcheron J, Talabard JN, Szafnicki K, Balique JG. Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia. Ann Chir. 2000;125:631\u201342.","journal-title":"Ann Chir"},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van SG, van TH. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.","journal-title":"J Clin Oncol"},{"key":"1430_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jso.10016","volume":"79","author":"E De Bree","year":"2002","unstructured":"De Bree E, Witkamp AJ, Zoetmulder FA. Intraperitoneal chemotherapy for colorectal cancer. J Surg Oncol. 2002;79:46\u201361.","journal-title":"J Surg Oncol"},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","volume":"16","author":"C Cao","year":"2009","unstructured":"Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152\u201365.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1430_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-7819-7-5","volume":"7","author":"G Glockzin","year":"2009","unstructured":"Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7(5):5.","journal-title":"World J Surg Oncol"},{"key":"1430_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00304298","volume":"9","author":"W Graf","year":"1994","unstructured":"Graf W, Westlin JE, Pahlman L, Glimelius B. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colorectal Dis. 1994;9:35\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"1430_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00000658-200004000-00001","volume":"231","author":"JC Vaillant","year":"2000","unstructured":"Vaillant JC, Nordlinger B, Deuffic S, Arnaud JP, Pelissier E, Favre JP, et al. Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Ann Surg. 2000;231:449\u201356.","journal-title":"Ann Surg"},{"key":"1430_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jso.21060","volume":"98","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Kusamura S, Baratti D, Deraco M. The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98:220\u20133.","journal-title":"J Surg Oncol"},{"key":"1430_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF00299188","volume":"19","author":"Y Yonemura","year":"1995","unstructured":"Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 1995;19:450\u20134.","journal-title":"World J Surg"},{"key":"1430_CR35","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/1097-0142(19941015)74:8<2224::AID-CNCR2820740804>3.0.CO;2-A","volume":"74","author":"DP Kelsen","year":"1994","unstructured":"Kelsen DP, Saltz L, Cohen a M, Yao TJ, Enker W, Tong W, et al. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer. 1994;74:2224\u201333.","journal-title":"Cancer"},{"key":"1430_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0360-3016(00)00474-0","volume":"47","author":"JA Palermo","year":"2000","unstructured":"Palermo JA, Richards F, Lohman KK, Lovelace JV, Atkinson J, Case LD, et al. Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2000;47:725\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1430_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/bjc.1998.225","volume":"77","author":"W Scheithauer","year":"1998","unstructured":"Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil\u2009+\u2009leucovorin vs fluorouracil\u2009+\u2009levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer. 1998;77:1349\u201354.","journal-title":"Br J Cancer"},{"issue":"3 Suppl 4","key":"1430_CR38","first-page":"101","volume":"12","author":"PH Sugarbaker","year":"1985","unstructured":"Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE. Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol. 1985;12(3 Suppl 4):101\u201311.","journal-title":"Semin Oncol"},{"key":"1430_CR39","doi-asserted-by":"crossref","unstructured":"Sloothaak DAM, Mirck B, Punt CJ a, Bemelman W a, van der Bilt JDW, D\u2019Hoore A, et al. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer. 2014;111(6):1112\u201321.","DOI":"10.1038\/bjc.2014.369"},{"key":"1430_CR40","doi-asserted-by":"crossref","unstructured":"Sloothaak DA, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJ, Buskens CJ, et al. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis. EurJSurgOncol. 2014;40(11):1453\u20138","DOI":"10.1016\/j.ejso.2014.06.012"},{"key":"1430_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","volume":"254","author":"D Elias","year":"2011","unstructured":"Elias D, Honore C, Dumont F, Ducreux M, Boige V, Malka D, et al. Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis. Ann Surg. 2011;254:289\u201393.","journal-title":"Ann Surg"},{"issue":"62","key":"1430_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1745-6215-11-62","volume":"11","author":"RT Ripley","year":"2010","unstructured":"Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials. 2010;11(62):62.","journal-title":"Trials"},{"key":"1430_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00019053-200725070-00005","volume":"25","author":"LM Lamers","year":"2007","unstructured":"Lamers LM, Uyl-de Groot CA, Buijt I. The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale. Pharmacoeconomics. 2007;25:591\u2013603.","journal-title":"Pharmacoeconomics"},{"key":"1430_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0167-6296(02)00120-0","volume":"22","author":"P Dolan","year":"2003","unstructured":"Dolan P, Stalmeier P. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic. J Health Econ. 2003;22:445\u201358.","journal-title":"J Health Econ"},{"key":"1430_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jso.23546","volume":"109","author":"D Hompes","year":"2014","unstructured":"Hompes D, D\u2019Hoore A, Wolthuis A, Fieuws S, Mirck B, Bruin S, et al. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. J Surg Oncol. 2014;109:527\u201332.","journal-title":"J Surg Oncol"},{"key":"1430_CR46","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.gassur.2006.01.011","volume":"10","author":"A Knutsen","year":"2006","unstructured":"Knutsen A, Sielaff TD, Greeno E, Tuttle TM. Staged laparoscopic infusion of hyperthermic intraperitoneal chemotherapy after cytoreductive surgery. J Gastrointest Surg. 2006;10:1038\u201343.","journal-title":"J Gastrointest Surg"},{"key":"1430_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2005.06.043","volume":"99","author":"G Ferron","year":"2005","unstructured":"Ferron G, Gesson-Paute A, Classe JM, Querleu D. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study. Gynecol Oncol. 2005;99:358\u201361.","journal-title":"Gynecol Oncol"},{"key":"1430_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1245\/s10434-007-9571-9","volume":"15","author":"A Gesson-Paute","year":"2008","unstructured":"Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15:339\u201344.","journal-title":"Ann Surg Oncol"},{"key":"1430_CR49","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00384-014-1929-4","volume":"29","author":"P Sammartino","year":"2014","unstructured":"Sammartino P, Sibio S, Biacchi D, Cardi M, Mingazzini P, Rosati MS, et al. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Colorectal Dis. 2014;29:1081\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"1430_CR50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ejso.2006.03.004","volume":"32","author":"D Elias","year":"2006","unstructured":"Elias D, Raynard B, Bonnay M, Pocard M. Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies. Eur J Surg Oncol. 2006;32:607\u201313.","journal-title":"Eur J Surg Oncol"},{"key":"1430_CR51","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1055-3207(03)00044-9","volume":"12","author":"O Glehen","year":"2003","unstructured":"Glehen O, Osinsky D, Beaujard AC, Gilly FN. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin NAm. 2003;12:729\u201339.","journal-title":"Surg Oncol Clin NAm"},{"key":"1430_CR52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/145749690309200213","volume":"92","author":"O Glehen","year":"2003","unstructured":"Glehen O, Gilly FN, Sugarbaker PH. New perspectives in the management of colorectal cancer: what about peritoneal carcinomatosis? Scand J Surg. 2003;92:178\u20139.","journal-title":"Scand J Surg"},{"key":"1430_CR53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/DCR.0b013e318197e351","volume":"52","author":"N Cheynel","year":"2009","unstructured":"Cheynel N, Cortet M, Lepage C, Ortega-Debalon P, Faivre J, Bouvier AM. Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population. Dis Colon Rectum. 2009;52:406\u201311.","journal-title":"Dis Colon Rectum"},{"key":"1430_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/PPO.0b013e3181a58f1d","volume":"15","author":"JH Lefevre","year":"2009","unstructured":"Lefevre JH, Elias DM. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence. Cancer J. 2009;15:200\u20133.","journal-title":"Cancer J"},{"key":"1430_CR55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/bjs.8679","volume":"99","author":"J Segelman","year":"2012","unstructured":"Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699\u2013705.","journal-title":"Br J Surg"},{"key":"1430_CR56","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545\u201350.","journal-title":"Br J Surg"},{"key":"1430_CR57","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/annonc\/mds173","volume":"23","author":"D Hompes","year":"2012","unstructured":"Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van CE, et al. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol. 2012;23:3123\u20139.","journal-title":"Ann Oncol"},{"key":"1430_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ejso.2013.10.001","volume":"40","author":"YRBM Van Gestel","year":"2014","unstructured":"Van Gestel YRBM, Thomassen I, Lemmens VEPP, Pruijt JFM, van Herk-Sukel MPP, Rutten HJT, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014;40:963\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1430_CR59","doi-asserted-by":"publisher","first-page":"141585","DOI":"10.1155\/2012\/141585","volume":"2012","author":"P Sammartino","year":"2012","unstructured":"Sammartino P, Sibio S, Biacchi D, Cardi M, Accarpio F, Mingazzini P, et al. Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract. 2012;2012:141585.","journal-title":"Gastroenterol Res Pract"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1430-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1430-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T21:14:47Z","timestamp":1691702087000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1430-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,24]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1430-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,24]]},"assertion":[{"value":"7 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"428"}}